Centre for Cancer & Inflammation

Our centre focuses on the links between cancer and inflammation. The overarching hypothesis that drives our research is that the inflammatory mediators and cells found in cancer are more likely to enhance than inhibit tumour progression; hence modulating these cells and mediators should be of therapeutic benefit.

Our aim is to translate our laboratory research in chronic inflammation and the tumour microenvironment into new treatments for cancer, especially ovarian and pancreatic cancer. We have been involved in several Phase I and Phase II clinical trials of cytokine antagonists and are currently planning other trials involving novel targets in the cancer microenvironment.

We also have a strong commitment to public engagement via the University's Centre of the Cell, an innovative and successful science centre and science outreach project for young people.

Click here to view the Group Leaders in the Centre

[accordion]

CanBuild

The European Research Council (ERC) has awarded Professor Fran Balkwill's team a €2.43million grant for a project that aims to revolutionise the field of cancer cell research: using bioengineering techniques to grow the first complex 3D human tumour in the laboratory.

News and links to further information about the project:

  • April 2013: CANBUILD grant award announced

[/accordion]

This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.